Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study

2017 ◽  
Vol 34 (8) ◽  
pp. 1067-1073 ◽  
Author(s):  
S. Johal ◽  
F. Jackson-Spence ◽  
H. Gillott ◽  
S. Tahir ◽  
J. Mytton ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cohort Study ◽  
Kidney Transplantation ◽  
Observational Cohort Study ◽  
Observational Cohort ◽  
Cellular Rejection

scholarly journals Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study

2019 ◽  
Vol 33 (5) ◽  
pp. e13517 ◽  
Author(s):  
Inga S. Thorsen ◽  
Inger H. Bleskestad ◽  
Anders Åsberg ◽  
Anders Hartmann ◽  
Øyvind Skadberg ◽  
...  
Keyword(s):  
Vitamin D ◽  
Risk Factor ◽  
Cohort Study ◽  
Kidney Transplantation ◽  
Patient Survival ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Observational Cohort

scholarly journals SP775MAGNESIUM AND THE INFECTION RISK AFTER KIDNEY TRANSPLANTATION: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii634-iii634
Author(s):  
Steven Van Laecke ◽  
Pieter Vermeiren ◽  
Evi V Nagler ◽  
Rogier Caluwe ◽  
Maarten De Wilde ◽  
...  
Keyword(s):  
Cohort Study ◽  
Kidney Transplantation ◽  
Infection Risk ◽  
Observational Cohort Study ◽  
Observational Cohort ◽  
Retrospective Observational Cohort Study

Magnesium and infection risk after kidney transplantation: An observational cohort study

2016 ◽  
Vol 73 (1) ◽  
pp. 8-17 ◽  
Author(s):  
Steven Van Laecke ◽  
Pieter Vermeiren ◽  
Evi V. Nagler ◽  
Rogier Caluwe ◽  
Maarten De Wilde ◽  
...  
Keyword(s):  
Cohort Study ◽  
Kidney Transplantation ◽  
Infection Risk ◽  
Observational Cohort Study ◽  
Observational Cohort

Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study

2016 ◽  
Vol 43 (8) ◽  
pp. 1475-1479 ◽  
Author(s):  
Yosuke Hattori ◽  
Toshihisa Kojima ◽  
Atsushi Kaneko ◽  
Daihei Kida ◽  
Yuji Hirano ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Risk Factors ◽  
Risk Factor ◽  
Cohort Study ◽  
Retention Rate ◽  
Significant Risk ◽  
Japanese Patients ◽  
Observational Cohort Study ◽  
Efficacy And Safety ◽  
Observational Cohort

Objective.To evaluate the rates of retention and discontinuation of adalimumab (ADA) due to efficacy and safety in Japanese patients with rheumatoid arthritis (RA).Methods.All patients with RA (n = 476) who were treated with ADA in the Tsurumai Biologics Communication Registry were enrolled.Results.The retention rate of ADA was 46% at 5 years. When focusing on insufficient efficacy, previous biologics use and high baseline disease activity were significant risk factors for up to 1 year. Methotrexate (MTX) use was a significantly low risk factor after 1 year of treatment.Conclusion.Concomitant MTX contributes to the longterm efficacy of ADA therapy.

Sign in / Sign up

Export Citation Format

Share Document